A new editorial article published in ISPOR’s Value in Health journal discusses the positive and negative consequences pharmaceutical and nonpharmaceutical measures in reducing the spread of COVID-19. The authors note serious global economic consequences upon implementation of social restrictions and call for continued HEOR (health economics and outcomes research) as we look beyond this pandemic.
The authors remark, “The May issue of Value in Health presents the second themed section on COVID-19. The first themed section was published in November 2020. Collectively, 11 articles in these 2 sections present important data and information on the cost-effectiveness, affordability, and impact of different COVID-19 interventions that can help further optimize the balance between prevention and treatment for societies around the globe…. An increasing role of health economics is needed to understand the value, affordability, and financing of pharmaceutical interventions in the postpandemic era by balancing humanistic and economic impacts.” Read more here.
(Source: Chhatwal & Postma, 4/15/2021)
